Suma Krishnan spent decades working for other people before building a $4 billion biotech company based on her own inventions. Today, one of her FDA-approved drugs holds potential solutions for rare genetic diseases. #ForbesOver50 (Photo: Jamel Toppin) https://t.co/sYamArAxIx https://t.co/J40JEOesfQ ...

Suma Krishnan spent decades working for other people before building a $4 billion biotech company based on her own inventions. Today, one of her FDA-approved drugs holds potential solutions for rare genetic diseases. #ForbesOver50 (Photo: Jamel Toppin) https://t.co/9i4D25Kt4f https://t.co/CpXT1dm0G2 ...